IMI:NSD-Intermolecular, Inc (USD)

COMMON STOCK | Other | NSD

Last Closing Price

USD 1.20

Change

0.00 (0.00)%

Market Cap

USD 0.06B

Average Target Price

N/A
Average Analyst Rating

Verdict

STA Verdict

Verdict

About

Intermolecular, Inc. engages in the development of advanced materials using high productivity combinatorial (HPC) technology platform for the semiconductors, consumer electronics, automotive, and aerospace industries worldwide. The company's HPC platform includes Tempus processing tools, automated characterization methods, and informatics analysis software for research and development using combinatorial process systems in concert with established chemical vapor deposition, physical vapor deposition, and atomic layer deposition methods. It serves various markets, including semiconductor, glass, advanced alloys, light-emitting diodes, flat-panel displays, and others. The company was formerly known as The BEP Group, Inc. and changed its name to Intermolecular, Inc. in November 2004. Intermolecular, Inc. was founded in 2004 and is headquartered in San Jose, California. As of September 20, 2019, Intermolecular, Inc. operates as a subsidiary of MERCK Kommanditgesellschaft auf Aktien.

Technical Indicators

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2020-02-22 )

Largest Industry Peers for Other

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
LGCY Legacy Reserves Inc

N/A

USD61,525,874.67B 1.10 -0.00
FTD FTD Companies, Inc

N/A

USD28,725,913.80B N/A -0.00
KEYW The KeyW Holding Corporation

N/A

USD24,651,104.38B 166.80 0.00
SNHY Helios Technologies, Inc

N/A

USD17,848,852.22B 1,000,000.00 -0.00
QTNA Quantenna Communications, Inc

N/A

USD8,997,243.52B 1,000,000.00 0.00
INSY INSYS Therapeutics, Inc

N/A

USD4,995,459.82B 115.90 -0.00
CHKE Apex Global Brands Inc

N/A

USD384,202.91B 17.30 0.00
AMCN AirNet Technology Inc

N/A

USD308,457.30B 1.00 -0.00
PDVW pdvWireless, Inc

N/A

USD95,944.74B N/A -0.00
AIPT Predictive Oncology Inc

N/A

USD38,513.36B N/A -0.00

ETFs Containing IMI

Symbol Name Weight Mer Price(Change) Market Cap

N/A

Market Performance

  Market Performance vs.
Industry/Classification (Other)
Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 14.29% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 14.29% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain -30.64% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return -30.64% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -4.26% 23% F 27% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -4.26% 23% F 25% F
Risk Return Profile  
Volatility (Standard Deviation) 38.73% 57% F 31% F
Risk Adjusted Return -11.00% 23% F 29% F
Market Capitalization 0.06B N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Other)
Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio N/A N/A N/A N/A N/A
Price/Book Ratio 2.15 N/A N/A N/A N/A
Price / Cash Flow Ratio 10.06 N/A N/A N/A N/A
EV/EBITDA -5.92 N/A N/A N/A N/A
Management Effectiveness  
Return on Equity -33.55% N/A N/A N/A N/A
Return on Invested Capital -11.21% N/A N/A N/A N/A
Return on Assets -16.07% N/A N/A N/A N/A
Debt to Equity Ratio N/A N/A N/A N/A N/A
Technical Ratios  
Short Ratio 0.03 N/A N/A N/A N/A
Short Percent 0.02% N/A N/A N/A N/A
Beta 0.57 N/A N/A N/A N/A
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

STA Verdict Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Positive cash flow

The company had positive total cash flow in the most recent four quarters.

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

Negative free cash flow

The company had negative total free cash flow in the most recent four quarters.